Skip to main content
Benjamin Kile

Professor Benjamin Kile

Executive Director

Executive Director of the Garvan Institute of Medical Research, Professor Benjamin Kile is an internationally recognised medical researcher who has made contributions to the understanding of cancer, stem cells and inflammatory disease. His work has shed light on the mechanisms of programmed cell death, informing the development of the BH3 mimetics, a new class of cancer drugs approved by the FDA in 2016. Professor Kile has a distinguished research leadership background, having occupied senior roles at the Walter and Eliza Hall Institute, Monash University, and the University of Adelaide. He made foundational contributions to the establishment of the National Drug Discovery Centre, the South Australian immunoGENomics Cancer Institute, and the Bragg Comprehensive Cancer Centre.


  • 2016Fellow - Australian Academy of Health and Medical Sciences
  • 2015Merck Millipore Research Medal - Australian Society for Biochemistry & Molecular Biology
  • 2013Committee for Melbourne Future Focus Group Jack Smorgon Alumni Award
  • 2013Gottschalk Medal of the Australian Academy of Science
  • 2011National Health and Medical Research Council 10 of the Best Research Projects 2011
  • 2010Australian Federal Government Science Minister's Prize for Life Scientist of the Year
  • 2008Burnet Prize of the Walter and Eliza Hall Institute
  • 2007Australian Institute of Policy and Science Young Tall Poppy Award
  • 2006Charles Perkins Centre Award for Outstanding Contributions to Cardiovascular Research
  • 2005International Society on Thrombosis and Haemostasis Young Investigator Award
  • 2005International Society on Thrombosis and Haemostasis Young Investigator Award
  • 1997Dean's Honour List - Faculty of Science - University of Melbourne